Repligen (RGEN) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $165.66 -1.31%
Revenue Growth %: -17.9%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -17.9%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.16, $0.02 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $47.7 million versus the consensus estimate of $46.08 million.
GUIDANCE:
Repligen sees FY2018 EPS of $0.69-$0.73, versus the consensus of $0.71. Repligen sees FY2018 revenue of $185-190 million, versus the consensus of $185.35 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
